Dl-Phenylalanine

Dl-Phenylalanine

SCHEMBL6494644

NC(Cc1ccccc1)C(=O)O.O=C(O)c1ccc(C(=O)c2ccccc2)cc1

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 4/20 0.71
ALPI P09923 1/20 0.71
PKM P14618 1/20 0.71
PTGS1 P23219 1/20 0.71
XIAP P98170 1/20 0.71
SRD5A2 P31213 4/20 0.58
SLC1A3 P43003 2/20 0.53
SLC1A2 P43004 2/20 0.53
SLC1A1 P43005 2/20 0.53
TPH1 P17752 2/20 0.53
NOS3 P29474 1/20 0.49
NOS1 P29475 1/20 0.49
NOS2 P35228 1/20 0.49
ANPEP P15144 1/20 0.49
ENPEP Q07075 1/20 0.49
SLC15A1 P46059 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylalanine SCHEMBL6494649 1.00 SLC7A5 (0.71) SLC7A5ALPIPKMPTGS1XIAP
Benzophenone SCHEMBL3857530 0.93 SLC7A5 (0.81) SLC7A5ALPIPKMPTGS1XIAP
Benzophenone SCHEMBL3857526 0.93 SLC7A5 (0.81) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL28091935 0.93 SLC7A5 (0.81) SLC7A5ALPIPKMPTGS1XIAP
SCHEMBL44097 0.92 SLC7A5 (0.72) SLC7A5ALPIPKMPTGS1XIAP
SCHEMBL288025 0.92 SLC7A5 (0.72) SLC7A5ALPIPKMPTGS1XIAP
SCHEMBL44096 0.92 SLC7A5 (0.72) SLC7A5ALPIPKMPTGS1XIAP
Terephthalamic Acid SCHEMBL28724671 0.87 SLC7A5 (0.71) SLC7A5ALPIPKMPTGS1XIAP
SCHEMBL19295504 0.86 SLC7A5 (0.69) SLC7A5ALPIPKMPTGS1XIAP
SCHEMBL157002 0.86 SLC7A5 (0.69) SLC7A5ALPIPKMPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6872850-B2 Small molecule inhibitors of secretion of proteins encoded by ARE-mRNAs MESSAGE PHARMACEUTICALS (US) 2005-03-29 US disclosed
WO-2002083842-A9 SMALL MOLECULE INHIBITORS OF SECRETION OF PROTEINS ENCODED BY ARE-MRNAS MESSAGE PHARMACEUTICALS INC (US) 2004-04-29 WO disclosed
US-20030199453-A1 Small molecule inhibitors of secretion of proteins encoded by ARE-mRNAs S. R. ONE, LIMITED 2003-10-23 US disclosed
WO-2002083842-A2 SMALL MOLECULE INHIBITORS OF SECRETION OF PROTEINS ENCODED BY ARE-MRNAS MESSAGE PHARMACEUTICALS, INC. (US) 2002-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030199453-A1 Small molecule inhibitors of secretion of proteins encoded by ARE-mRNAs ASF1A, IGF2BP1, SERBP1 SLC7A5 778/4885ALPI 3992/4885PKM 4458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.